Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Sankyo describes NK1/NK2 antagonists for treating asthma

Aug. 25, 1998

First European filing for TOBI

Aug. 24, 1998

Tanabe Seiyaku team identifies new candidates for asthma

Aug. 21, 1998

More PDE4 inhibitors described by Byk Gulden

Aug. 20, 1998

TA-270 inhibits the immediate and late asthmatic response and blocks DTH in animal studies

Aug. 19, 1998

SynPhar's HLE inhibitors show unique potential in preventing lung injury

Aug. 18, 1998

Two new series of PDE4 inhibitors reported by Byk Gulden

Aug. 18, 1998

Schering-Plough patents new tachykinin NK1/NK2 antagonists

Aug. 14, 1998

More PDE IVA inhibitors in the pipeline at Kyowa Hakko

Aug. 13, 1998

Menarini's NK1 antagonist MEN-11467 shows promising antiasthmatic activity

Aug. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...